Sort
10,766 grants matching “checkpoint inhibitor”
Evaluation of treatment predictors reflecting beta-catenin activation in hepatocellular carcinoma
$238,598Sandi Alexander Kwee · Queen'S Medical Center · R01 · FY2022 · CA
Genomics Core
$238,562Jaroslav Jelinek · Coriell Institute For Medical Research · P50 · FY2024 · CA
Targeted manipulation of the DNA damage response for prevention/treatment of GVHD
$238,500Michael Jordan · Cincinnati Childrens Hosp Med Ctr · R21 · FY2019 · AI
First in Human Trials of ProAgio, a Cytotoxin
$238,460Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Biochemical Basis for Therapeutic Activity
$238,029William K Plunkett · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA
Biochemical Basis for Therapeutic Activity
$238,029William K Plunkett · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA
Advancing WRN as a synthetic lethal target for microsatellite unstable Cancers
$237,994Edmond Chan · Dana-Farber Cancer Inst · K08 · FY2021 · CA
Simultaneous Radiotherapy with PD-1 and IDO1 Blockade for Overcoming Immune Suppression in Glioblastoma
$237,852Derek Alan Wainwright · Northwestern University At Chicago · P50 · FY2021 · CA
Project 3: Modulating Androgen Receptor Signaling to Enhance the Efficacy of CAR T Cell Therapy for Advanced Prostate Cancer
$237,841John Kyung Lee · Fred Hutchinson Cancer Center · P50 · FY2025 · CA
ASPECTS OF UTERINE CELL CYCLE REGULATION IN IMPLANTATION
$237,825Vanderbilt University · R01 · FY2005 · HD
ASPECTS OF UTERINE CELL CYCLE REGULATION IN IMPLANTATION
$237,825Vanderbilt University · R01 · FY2003 · HD
ASPECTS OF UTERINE CELL CYCLE REGULATION IN IMPLANTATION
$237,825Vanderbilt University · R01 · FY2004 · HD
Role of Neutrophil Extracellular Traps in Pancreatic Cancer
$237,784Brian A Boone · West Virginia University · P20 · FY2023 · GM
Targeting ROS enzymes in immunosuppressive myeloid cells to enhance immunotherapy
$237,783Tracy W Liu · West Virginia University · P20 · FY2023 · GM
Proteasome subunit beta5t and thymus-specific peptides in T cell selection
$237,750John J. Monaco · University Of Cincinnati · R21 · FY2014 · AI
Tetraacylated lipid A enhancement of checkpoint blocking cancer immunotherapy
$237,724Dennis L. Kasper · Harvard Medical School · R21 · FY2024 · CA
Precision use of radiation for in situ cancer immunization
$237,724Sandra Demaria · Weill Medical Coll Of Cornell Univ · R21 · FY2025 · CA
A germline variant that predicts and modulates the response of melanoma to immunotherapy
$237,724Iman Osman · New York University School Of Medicine · R21 · FY2018 · CA
Novel targets of treatment for NF1-mutant melanoma
$237,724Iman Osman · New York University School Of Medicine · R21 · FY2021 · CA
Defining host-microbiota interactions during colorectal cancer and immune checkpoint blockade
$237,724Gregory F Sonnenberg · Weill Medical Coll Of Cornell Univ · R21 · FY2021 · CA
NMR detection of tumor differentiation
$237,454Edward J Delikatny · University Of Pennsylvania · R01 · FY2009 · CA
NMR detection of tumor differentiation
$237,454Edward J Delikatny · University Of Pennsylvania · R01 · FY2007 · CA
NMR detection of tumor differentiation
$237,454Edward J Delikatny · University Of Pennsylvania · R01 · FY2008 · CA
Partnerships for Biomedical Research in Arkansas
$237,350Lawrence E Cornett · Univ Of Arkansas For Med Scis · P20 · FY2022 · GM
Core Support for Cancer Center
$237,147Edward Chu · Albert Einstein College Of Medicine · P30 · FY2021 · CA